Brief: Biostage presents positive preclincal data
06/04/2017 12:05
April 6 (Reuters) - Biostage Inc BSTG.O :
* Biostage presents positive preclincal data of cellspan
esophageal implant at society for biomaterials 2017 annual
meeting and exposition
* Biostage- Data showed cellspan implant carried
metabolically active cells that released bioactive molecules
involved in mesenchymal cells paracrine function
* Biostage Inc - full mucosal regeneration on inner lumen
was observed within a span of 3 months post-implantation
Source text for Eikon: ID:nPn3lC6BYa
Further company coverage: BSTG.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Harvard Apparatus Regenerative Technology
See all newsBrief: Harvard Apparatus Regenerative Technology Announces Strategic Collaboration With Children’S Hospital Capital Institute Of Pediatrics In Beijing, China To Advance Treatment For Esophageal Atresia
Brief: Biostage Activated Mayo Clinic As The First Site For Clinical Trial In Severe Esophageal Disease
Brief: Biostage Amends CEO Employment Agreement
Brief: Biostage Inc Files For Firm Commitment Public Offering Of 1.03 Million Units - SEC Filing
Brief: Biostage Announces Appointment Of New Chief Financial Officer